www.oldsilvervc.com Open in urlscan Pro
54.194.170.100  Public Scan

Form analysis
0 forms found in the DOM

Text Content

HomeAboutTeam AdvisorsPortfolioContact


 * 
 * About
 * Team ▾
   Advisors
   PortfolioContact
 * 

About











Team











Portfolio











Contact















ABOUT

Old Silver VC is an evergreen family-associated fund that makes early stage
investments in Biotech, Digital Health, AI, and Material Sciences. We believe
that the world’s greatest problems can be solved with innovative science and
technology solutions. We seek and support early-stage founders with a vision
that can scale from science fiction to new reality.


ARTIFICIAL INTELLIGENCE





MATERIAL SCIENCES






BIOTECHNOLOGY


DIGITAL HEALTH


BIOTECHNOLOGY


ARTIFICIAL INTELLIGENCE





DIGITAL HEALTH


MATERIAL SCIENCES





TEAM


KNOWLEDGE, EXPERIENCE,
KINDNESS

Michael Langer
Founding Partner

Michael is the Founding Partner at Old Silver VC, the Head of Search and
Evaluation at Pear Therapeutics and a World Economic Forum Global Shaper.

Susan Langer
Venture Partner

Vice President of Business Development at a Cambridge-based cell state start up
in stealth mode.

Andrew Emmons, MBA
Managing Director

Focuses on early-stage investments in the technology, SaaS, and healthcare
industries.

Eric Shen
Managing Director

Well versed in corporate development and strategic & operational excellence
focusing on biotechnology and healthcare.

Matthew Lanchantin
Managing Director

Corporate strategy & development at Valo Health, head of partnerships &
licensing at 2 Minute Medicine, co-founder and board director at Nucleate Bio.
Fund advisor specializing in translational biotechnology,  AI drug discovery and
platform strategy.




FELLOWS

Cassandra Villicana


PhD Candidate at Stanford University researching biomaterial-based
immunomodulation strategies for tissue engineering

David Paik, PhD


Instructor at Stanford Cardiovascular Institute and Stanford University School
of Medicine. Current focus of research is in advancing cardiovascular precision
medicine using single-cell omics and patient-specific induced pluripotent stem
cell models.

Hannah Bolland, PhD


Postdoctoral researcher at Oxford University working in the field of tumour
hypoxia, reactive oxygen species and development of novel fluorescent and
responsive MRI probes to measure hypoxia.

Kimberly Tran


Undergraduate at Princeton University researching breast cancer bone metastasis
and application of scRNA-seq technology

Kui Wu


Dartmouth Tuck MBA candidate with experience in biopharma R&D, project
management, corporate and business development, and venture capital.

Lara Maggs, MBE


PhD candidate in genetics and molecular biology studying translation synthesis,
a DNA damage response pathway in which specialized polymerases traverse blocking
DNA lesions. Bioethicist focused on the ethical implications of germline gene
editing.

Michael Trinh, PhD


MD-PhD candidate at the University of Texas Southwestern Medical Center studying
cholesterol metabolism

Sunil Yadav, PhD


Postdoctoral researcher at Stanford University School of Medicine researching
targeted therapies for genetic cardiomyopathies.

Tiffany Ma, MTM


PhD candidate at the University of Oxford researching strategies to target
therapy-resistant tumours in solid cancers.


ADVISORS

Adam Śmiechowski


Senior software engineer at Microsoft whose expertise spans multiple verticals
of the software engineering domains and a number of programming languages
including C, C++, C# and Python.

Alicia Chong Rodriguez, MS, MSc


Femtech Catalyst, Founder & CEO at Bloomer Tech: Tailoring cardiovascular care
for women via an augmented garment platform and novel digital biomarkers.

Debbie Lin, PhD


Healthtech investor is currently excited about digital health, med devices, new
materials, AI and drug discovery tools.

David Mou, MBA, MD


Chief Medical Officer at Cerebral & Co-founder / former CMO of Valera Health, a
venture-backed digital healthcare company.

Emilia Javorsky, MD, MPH


Physician-Scientist and former Harvard Medical School researcher focused on the
development and translation of medical technologies.

Everett Crosland, MS, JD


Life sciences executive, with a proven track record commercializing and scaling
complex drugs, drug-device combos, and digital therapeutics.

Giovanni Thermot


Co-founder of ThoughtMetric Inc- a next-generation analytics platform designed
to help Mid-Market and SMB eCommerce stores better understand their customers.

Jordan Haviland, MBA


CEO of Brattle Point, LLC, where he focuses on acquiring growing technology and
service businesses in scientific and industrial markets.

Livio Valenti, MPP


Sustainability entrepreneur and co-founder of Vaxess Technologies, a
biotechnology company reimagining vaccine delivery.

Liz Kwo, MD, MBA, MPH


Deputy Chief Clinical Officer at Anthem & Co-Founder / former CEO of InfiniteMD.

Louis Kang, PhD


Managing Director at AccelR8, Co-Founder at MitoLab, Venture Partner at Korea
Technology Bank (KTB) VC

Medha Sharma


M.D. candidate at the Perelman School of Medicine passionate about innovation in
biotech, digital health, and health equity.

Milad Alucozai


Head of Bio & Deep Tech at BoxOne Ventures, Venture Partner at Entrepreneur
First, and active angel investor. A neuroscientist by training, turned
entrepreneur, and active investor. Appointed as a Strategic Advisor to LifeOmic,
and as an External Advisor to AstraZeneca.

Millie Liu


Founding Partner at First Star Ventures, an early-stage venture fund focuses on
cutting edge data technologies.

Pavan Choksi


Partner at Arkitekt Ventures

Rebecca Maynard, LLM, JD


Compliance & Privacy Specialist at Boston Children's Hospital

Rose Wang


Head of CX at NLP startup Forethought.ai, winner of TechCrunch Disrupt and
funded by NEA, Village Global, K9 Ventures, etc.

Ryan Coles, MS, PHD


Assistant Professor of Entrepreneurial Management at UConn's School of Business,
and the Chief Science Officer at Human Wealth.

Sean Cheng, MP, PHD


Early stage investor in health tech companies and is currently excited about
digital therapeutics, remote patient care, novel devices, and disruptive
enablers.

Sophie Bai, MBA


Founder and CEO of a biotech company using novel transdermal drug delivery
technologies to get large molecules into the skin.

Zack Gow, ME, MS


Data scientist, machine learning engineer, and entrepreneur.

Freddie Martignetti, MBA
Senior Advisor

Investor at Highland Capital Partners, a global leader in early stage consumer
and enterprise technology investments.

Robert Langer, Sc. D
Senior Advisor

Dr. Langer is one of 10 Institute professors at MIT (MITs highest honor). He is
an expert in the fields of tissue engineering and drug delivery and has founded
over 40 startup companies. He is the most cited engineer in history. 

OLD SILVER



NEW SILVER





PORTFOLIO

ACQ
IPO

The world's only multi-lead ECG heart health wearable bra.

Visit The Site
ACQ
IPO

Developing technology to drive the mining industry into a new place of increased
output, stronger economics, and long term sustainability.

Visit The Site
ACQ
IPO

Replacing chemicals banned by the FDA with 100% sustainable and safe ingredients
from recycled marine biomaterials (branded OceanSafe™).

Visit The Site
ACQ
IPO

Building the metaverse for 'new work'. Forward-looking companies move in to
virtual offices in Sophya to build culture and achieve business results.

Visit The Site
ACQ
IPO

Developing a platform to mass produce insects as the world’s most sustainable
protein.

Visit The Site
ACQ
IPO

Improving human health by making it far easier to design advanced,
next-generation antibody therapeutics.

Visit The Site
ACQ
IPO

Cultivated meat start-up pioneering a new approach to producing meat by growing
real meat cells without the animal, enabling a sustainable supply chain as well
as a more resilient food ecosystem.

Visit The Site
ACQ
IPO

Extremely robust, end-to-end plant genetic engineering platform–from
bioinformatics-based trait discovery to regenerative protoplast testing to
greenhouse/field testing.

Visit The Site
ACQ
IPO

Making a major shift in how immunology therapies are discovered and developed by
integrating machine learning together with protein engineering, structural
biology and translational immunology throughout the entire drug discovery and
development process.

Visit The Site
ACQ
IPO

The pioneer of a new, accessible healthcare system that connects the millions of
uninsured and underserved Americans to superior physicians at half of the
traditional price

Visit The Site
ACQ
IPO

An automated lab platform for life sciences transforming healthcare, biopharma,
and R&D

Visit The Site


PRIOR INVESTMENTS OR EARLY SHAREHOLDER POSITIONS

ACQ
IPO

A full-service pharmacy that delivers prescriptions to your door for free, seven
days a week. 

Visit The Site
ACQ
IPO

Using machine learning to make customizable voice skins for the gaming industry.

Visit The Site
ACQ
IPO

Medical marijuana dispensary.

Visit The Site
ACQ
IPO

Creating a new frontier in visual and neurological care that extracts the full
value of virtual reality technology. 

Visit The Site
ACQ
IPO

An AI powered search engine to optimize drug discovery for pharmaceutical
companies.

Visit The Site
ACQ
IPO

Creating animal-free materials that deliver design and performance with
sustainable impact.

Visit The Site
ACQ
IPO

A global biotech company builder that leverages a decentralized, technology- and
data-driven platform model to serve millions of people suffering with mental
health disorders.

Visit The Site
ACQ
IPO

Creating all-natural protective layers to slow down the spoiling process of
fruit, vegetables, meat, and seafood.

Visit The Site
ACQ
IPO

An American biotechnology company based in Cambridge, Massachusetts that focus
on drug discovery, drug development, and vaccine technologies based exclusively
on messenger RNA.

Visit The Site
ACQ
IPO

A clinical-stage biotechnology company focused on harnessing the body’s innate
biology to repair or reverse damage caused by a broad range of degenerative
diseases.

Visit The Site
ACQ
IPO

A biopharmaceutical company focused on the discovery, development and
commercialization of RNA interference therapeutics for genetically defined
diseases.

Visit The Site
ACQ
IPO

Momenta Pharmaceuticals is a biotechnology company with a validated, innovative
scientific platform.

Visit The Site
ACQ
IPO

A biopharmaceutical company committed to advancing the treatment of eye
diseases.

Visit The Site
ACQ
IPO

Lyndra Therapeutics is a developer of a novel therapeutic platform designed to
sustain extended drug release in oral dosage form.

Visit The Site
ACQ
IPO

Creating immune-protected, engineered human cells that restore normal physiology
in a wide range of diseases without generating fibrosis or immune rejection,
liberating patients from challenges associated with serious chronic diseases

Visit The Site
ACQ
IPO

Developing innovative solutions that act as a gateway to the proteome.

Visit The Site
ACQ
IPO

A clinical-stage biotechnology company developing transformative cell therapies
for patients with cancer, infectious diseases, and other serious conditions.

Visit The Site
ACQ
IPO

Cruelty-free, paraben-free & silicone-free haircare products.

Visit The Site
ACQ
IPO

Vida Ventures is a bio-coastal life sciences company transforming biomedical
innovations into therapies.

Visit The Site
ACQ
IPO

A Boston based seed fund focused on consumer digital, sports & marketplaces, and
AI, data & security.

Visit The Site


CONTACT


IF YOU'RE BUILDING SOMETHING PEOPLE SAY ISN’T GOING TO WORK, PLEASE MESSAGE US,
WE WOULD LOVE TO TALK.


ANDREW@OLDSILVERVC.COM

AboutTeamPortfolioContact

Made with ♥︎ by 23cubed